All stock lists
Cardinal Health Inc (CAH)
NYSE: CAH · Real-Time Price · USD
Healthcare · Medical Distribution
252.50+2.93 (+1.17%)
Insider Score
––Not scored
CAH Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CAH analyst forecast
CAH analyst consensus
No analyst ratings in the last 3 months.
CAH 12-month price target
$263.89+4.9% upsideaverage of 9 firms
$295.00High
$240.00Low
Best analysts covering CAH
No firm covering CAH has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CAH analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| UBS | — | $295.00 | +16.3% | — | 2026-10-16 | |
| RBC Capital | — | $276.00 | +17.5% | — | 2026-08-19 | |
| Wells Fargo | — | $277.00 | +15.3% | — | 2026-08-12 | |
| Mizuho Securities | — | $250.00 | +4.1% | — | 2026-08-12 | |
| Robert W. Baird | — | $274.00 | +14.0% | — | 2026-08-12 | |
| Evercore ISI | — | $240.00 | +11.6% | — | 2026-04-08 | |
| Leerink Partners | — | $275.00 | +23.7% | — | 2026-03-09 | |
| UBS | — | $260.00 | +13.7% | — | 2026-02-06 | |
| Mizuho Securities | — | $235.00 | +3.4% | — | 2026-02-06 | |
| Evercore ISI | — | $260.00 | +14.4% | — | 2026-02-05 | |
| Morgan Stanley | — | $245.00 | +16.5% | — | 2026-01-29 | |
| Robert W. Baird | — | $250.00 | +17.9% | — | 2026-01-14 | |
| Leerink Partners | — | $240.00 | +15.3% | — | 2026-01-13 | |
| Mizuho Securities | — | $222.00 | +10.4% | — | 2026-01-12 | |
| Barclays | — | $243.00 | +22.2% | — | 2025-12-08 | |
| Mizuho Securities | — | $210.00 | +10.4% | — | 2025-11-03 | |
| Evercore ISI | — | $220.00 | +15.0% | — | 2025-10-31 | |
| Leerink Partners | — | $186.00 | +27.1% | — | 2025-08-12 | |
| Jefferies | — | $150.00 | -4.9% | — | 2025-08-12 | |
| Morgan Stanley | — | $181.00 | +12.1% | — | 2025-06-13 | |
| Wells Fargo | — | $179.00 | +15.1% | — | 2025-06-03 | |
| Argus Research | — | $148.00 | +18.2% | — | 2025-02-04 | |
| Robert W. Baird | — | $140.00 | +24.7% | — | 2024-09-23 | |
| Argus Research | — | $125.00 | +11.2% | — | 2024-09-11 | |
| Deutsche Bank | — | $119.00 | +10.3% | — | 2024-08-16 | |
| Evercore ISI | — | $115.00 | +6.8% | — | 2024-08-15 | |
| Morgan Stanley | — | $119.00 | +11.9% | — | 2024-08-15 | |
| Mizuho Securities | — | $110.00 | +2.4% | — | 2024-08-15 | |
| Robert W. Baird | — | $137.00 | +27.6% | — | 2024-08-15 | |
| Wells Fargo | — | $101.00 | -5.0% | — | 2024-08-15 | |
| CFRA | — | $111.00 | +12.1% | — | 2024-06-11 | |
| Robert W. Baird | — | $129.00 | +36.1% | — | 2024-05-29 | |
| Argus Research | — | $115.00 | +18.0% | — | 2024-05-15 | |
| Robert W. Baird | — | $128.00 | +24.3% | — | 2024-05-03 | |
| Robert W. Baird | — | $134.00 | +21.7% | — | 2024-04-05 | |
| Morgan Stanley | — | $90.00 | -3.2% | — | 2023-08-15 | |
| Wolfe Research | — | $127.00 | +60.4% | — | 2023-04-12 | |
| Robert W. Baird | — | $94.00 | +19.6% | — | 2023-02-08 | |
| Evercore ISI | — | $68.00 | +21.8% | — | 2022-05-20 | |
| Deutsche Bank | — | $51.00 | -12.5% | — | 2022-05-08 | |
| Morgan Stanley | — | $74.00 | +17.5% | — | 2022-04-16 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.